MEI Pharma
(NASDAQ:MEIP)
$3.80
-0.15[-3.80%]
Last update: 6:34PM Get Real Time Here
Consensus Rating1
Hold
Highest Price Target1
$80.00
Lowest Price Target1
$0.10
Consensus Price Target1
$13.01

MEI Pharma Stock (NASDAQ:MEIP), Analyst Ratings, Price Targets, Predictions

MEI Pharma Inc has a consensus price target of $13.01, established from looking at the 15 latest analyst ratings. The last 3 analyst ratings were released from Stifel, Stifel, and Brookline Capital on February 14, 2024, September 27, 2023, and May 23, 2023. With an average price target of $32 between Stifel, Stifel, and Brookline Capital, there's an implied 742.11% upside for MEI Pharma Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Feb
0
0
0
0
0
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Stifel
Brookline Capital
HC Wainwright & Co.
Jefferies
BTIG

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for MEI Pharma

date
▲▼
ticker
▲▼
Buy Now
Company
▲▼
Current price
▲▼
Upside/Downside
▲▼
Analyst Firm
▲▼
Analyst & % Accurate
▲▼
Price Target Change
▲▼
Rating Change
▲▼
Previous / Current Rating
▲▼
Get Alert
02/14/2024MEIPBuy Now
MEI Pharma
$3.8084.21%Stifel
Stephen Willey
$8 → $7MaintainsHoldGet Alert
09/27/2023MEIPBuy Now
MEI Pharma
$3.80136.84%Stifel
Stephen Willey
$10 → $9MaintainsHoldGet Alert
05/23/2023MEIPBuy Now
MEI Pharma
$3.802005.26%Brookline Capital
Leah Cann
→ $80MaintainsBuyGet Alert
05/12/2023MEIPBuy Now
MEI Pharma
$3.80163.16%Stifel
Stephen Willey
$0.5 → $10MaintainsHoldGet Alert
02/13/2023MEIPBuy Now
MEI Pharma
$3.80-47.37%HC Wainwright & Co.
Andrew Fein
$100 → $40MaintainsBuyGet Alert
02/08/2023MEIPBuy Now
MEI Pharma
$3.80-97.37%Jefferies
Chris Howerton
$8 → $2DowngradeHold → UnderperformGet Alert
12/06/2022MEIPBuy Now
MEI Pharma
$3.80—BTIG
Justin Zelin
—DowngradeBuy → NeutralGet Alert
12/06/2022MEIPBuy Now
MEI Pharma
$3.80—Truist Securities
Robyn Karnauskas
—DowngradeBuy → HoldGet Alert
03/25/2022MEIPBuy Now
MEI Pharma
$3.805.26%BTIG
Justin Zelin
$220 → $80MaintainsBuyGet Alert
03/25/2022MEIPBuy Now
MEI Pharma
$3.80-21.05%Truist Securities
Robyn Karnauskas
$160 → $60MaintainsBuyGet Alert
03/25/2022MEIPBuy Now
MEI Pharma
$3.8031.58%HC Wainwright & Co.
Andrew Fein
$200 → $100MaintainsBuyGet Alert
03/25/2022MEIPBuy Now
MEI Pharma
$3.80-47.37%Wells Fargo
Jim Birchenough
$260 → $40DowngradeOverweight → Equal-WeightGet Alert
03/25/2022MEIPBuy Now
MEI Pharma
$3.80-47.37%Stifel
Stephen Willey
$120 → $40DowngradeBuy → HoldGet Alert
03/25/2022MEIPBuy Now
MEI Pharma
$3.80-73.68%Jefferies
Chris Howerton
$80 → $20DowngradeBuy → HoldGet Alert
02/03/2022MEIPBuy Now
MEI Pharma
$3.805.26%Jefferies
Chris Howerton
→ $80Initiates → BuyGet Alert

FAQ

Q

What is the target price for MEI Pharma (MEIP)?

A

The latest price target for MEI Pharma (NASDAQ: MEIP) was reported by Stifel on February 14, 2024. The analyst firm set a price target for $7.00 expecting MEIP to rise to within 12 months (a possible 84.21% upside). 4 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for MEI Pharma (MEIP)?

A

The latest analyst rating for MEI Pharma (NASDAQ: MEIP) was provided by Stifel, and MEI Pharma maintained their hold rating.

Q

When was the last upgrade for MEI Pharma (MEIP)?

A

There is no last upgrade for MEI Pharma.

Q

When was the last downgrade for MEI Pharma (MEIP)?

A

The last downgrade for MEI Pharma Inc happened on February 8, 2023 when Jefferies changed their price target from $0.4 to $0.1 for MEI Pharma Inc.

Q

When is the next analyst rating going to be posted or updated for MEI Pharma (MEIP)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MEI Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MEI Pharma was filed on February 14, 2024 so you should expect the next rating to be made available sometime around February 14, 2025.

Q

Is the Analyst Rating MEI Pharma (MEIP) correct?

A

While ratings are subjective and will change, the latest MEI Pharma (MEIP) rating was a maintained with a price target of $8.00 to $7.00. The current price MEI Pharma (MEIP) is trading at is $3.80, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch